Skip to main content

Validity of the IUATLD (1986) questionnaire in the EGEA study

Buy Article:

$34.78 + tax (Refund Policy)

SETTING: No validity study of the IUATLD asthma-like questions has been performed in a group of well-defined, clinically-based asthmatics.

OBJECTIVES: To assess the validity of the questions regarding asthmatics included in a case-control study, and to assess their validity as regards bronchial hyperresponsiveness in population-based subjects.

DESIGN: Data from the case-control Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy (EGEA) were used. The analysis concerned 201 adult asthmatic cases recruited in chest clinics through a standardised protocol and 284 population-based controls.

RESULTS: The analysis of the case-control study regarding asthma showed a sensitivity of 0.56, 0.68 and 0.86 for nocturnal symptoms of cough, shortness of breath, and chest tightness, and a specificity of 0.72, 0.98 and 0.89. As regards bronchial hyperresponsiveness (PD20 ≤4 mg) in the control group, specificity was high (0.77, 0.99 and 0.90), but sensitivity was markedly lower (0.36, 0.11 and 0.20).

CONCLUSION: Asthma-like symptoms assessed by the IUATLD questionnaire have good validity, both for specificity and sensitivity, for asthma patients recruited in chest clinics. In general populations, questions have a high specificity, an important criterion in aetiological epidemiological research, and they were designed in that perspective. However their moderate sensitivity limits their usefulness as a screening test.

Keywords: case-control; epidemiology; questionnaire; validity

Document Type: Regular Paper

Affiliations: INSERM (Institut National de la Santé et de la Recherche Médicale) U472, Villejuif, France

Publication date: 01 February 2001

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content